Release Date: September 12, 2018 Expiration Date: October 31, 2019 (subject to change)
CE for this activity will not be available after this date.
Conference Level: Proficient Overview The nationally vetted safe opioid prescribing standards using the FDA blueprint and CO*RE content are presented. Content discusses (1) pain assessment and screening tool recommendations; (2) opioid trial components including patient, provider agreements and informed consent use, and expected activities during the prescription trial phase of treatment including the decision to stop treatment; (3) components of long term therapy including ongoing assessment tool use, urine drug testing frequency, updating PPA and informed consents; and (4) issues related to termination of care. Red flag behaviors are discussed as well as complex pain management case studies. Pharmacology information includes the CO*RE content on immediate and long acting opioid use, equal analgesic dose changes, drug families and new drug formulations.
This CE activity is a recording of a CE session from the AANP 2018 National Conference. It has been edited to meet the format requirements for online learning. If you received CE credit for attending the live session at Conference, you many not receive duplicate credit for this same activity in a different format. CE Credit Instructions
Read this activity description, including objectives and disclosures.
Complete the educational content completely:
Video Presentations: Watch all video presentations completely.
Review all additional materials provided (handouts, posttest reviews, any other downloadable resources).
After completing all content, go to Steps to Receive Credit to complete the posttest and evaluation to receive full AANP CE/Rx credit. If other types of credit are offered, these options will be available after completing the activity evaluation.
Accurately assess patients with pain for consideration of an opioid trial
Establish realistic goals for pain management and restoration of function
Initiate opioid treatment (IR and ER/LA) safely and judiciously, maximizing efficacy while minimizing risks
Monitor and re-evaluate treatment continuously; discontinue safely when appropriate
Counsel patients and caregivers about use, misuse, abuse, diversion, and overdose
Educate patients about safe storage and disposal of opioids
Demonstrate working knowledge and ability to access general and specific information about opioids, especially those used in your practice
Faculty Randall S. Hudspeth, PhD, APRN-CNP, FAANP Kathleen Broglio DNP, ANP-BC, ACHPN, CPE, FPCN Disclosure This activity was planned in accordance with AANP Accreditation Standards and Policies. Dr. Hudspeth and Dr. Broglio have no relevant affiliations to disclose. This educational activity may contain opinions of the speakers from their personal experience. The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program. Additional Information For questions about this online CE activity, or more information concerning the AANP CE Center, contact the AANP CE Center Manager at CECenter@aanp.org.
3 Contact Hour(s) of CE, All of which may be applied towards Pharmacology